Skip to main content

Closed

SYRE: Spyre Therapeutics, Inc. Company Profile & Overview | finqOS

Healthcare · Biotechnology

52W Range

93thpctl

Volume

0.43×avg

Market Cap

8.54BUSD

P/E Ratio

-45.1TTM

Div Yield

-ann

Spyre Therapeutics, Inc.

SYRENASDAQ Capital Market·USD·Closed

Spyre Therapeutics, Inc.

SYRENASDAQ·USD·Closed

$98.33

−3.12%

$98.33

−$3.17 (3.12%)

52W Range

93thpctl

Volume

0.43×avg

Mkt Cap

8.54BUSD

P/E

-45.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings